Search

Search Constraints

You searched for: Author/Creator Mozas, Pablo

Search Results

1. A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma. Issue 1 (2nd January 2021)

2. Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma. (16th November 2020)

3. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPI. Issue 4 (13th February 2017)

4. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPI. Issue 4 (13th February 2017)

5. Early progression in follicular lymphoma in the absence of histological transformation or high‐risk Follicular Lymphoma International Prognostic Index still has a favourable outcome. (19th October 2022)

6. First external validation of the FLIPI‐L score in a single‐center series of patients with follicular lymphoma. Issue 2 (7th December 2021)

7. Flow cytometry to detect bone marrow involvement by follicular lymphoma. Issue 6 (31st October 2022)

8. High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era. (July 2020)

9. Is there a role for minimal residual disease monitoring in the management of patients with hairy‐cell leukaemia?. (18th August 2017)